Immunotherapy

Several of these new therapies are now regarded as a first-line treatment for some cancers alongside the traditional approaches of surgery, radiation, and chemotherapy. 

Even with some immunotherapy treatments available, more are currently being tested in a large number of clinical trials. Holden Comprehensive Cancer Center is at the forefront of many of these clinical trials including the testing of unique cancer immunotherapeutic approaches developed at Holden.

Monoclonal Antibodies

These are human-made versions of immune system proteins that boost the natural immune response.

Immune Checkpoint

Inhibitors These medicines help the immune system to kill cancer cells by making it more difficult for cancer cells to avoid the immune system.

Cancer Vaccines

These medicines are put into the body to start an immune response against cancer.

CAR T-cell therapy

This treatment uses genetically improved versions of your own white blood cells to find and kill cancer cells in your body.

Cellular Therapy

This approach involves taking immune cells out of the body and manipulating them so they are more effective at fighting the cancer. One form of cellular therapy is chimeric antigen receptor (CAR) T-cell therapy.